Cellix Bio Pharma Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 22-06-2024
- Paid Up Capital ₹ 33.33 K
as on 22-06-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 72.61%
(FY 2022)
- Ebitda 77.58%
(FY 2022)
- Net Worth -0.33%
(FY 2022)
- Total Assets 9.45%
(FY 2022)
About Cellix Bio Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 33.33 K , as per Ministry of Corporate Affairs (MCA) records.
Sridhar Koganti, Subramaniam Apparsundaram, and Mahesh Kandula serve as directors at the Company.
- CIN/LLPIN
U73100TG2020PTC138576
- Company No.
138576
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Cellix Bio Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subramaniam Apparsundaram  | Director | 21-Jan-2020 | Current |
Mahesh Kandula  | Director | 21-Jan-2020 | Current |
| Sridhar Koganti | Additional Director | Current |
Financial Performance of Cellix Bio Pharma.
Cellix Bio Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 72.61% increase in profit. The company's net worth dipped by a decrease of 0.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cellix Bio Pharma?
In 2020, Cellix Bio Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Avaca Pharma Private LimitedActive 8 years 2 monthsSridhar Koganti and Mahesh Kandula are mutual person
Cellix Bio Private LimitedActive 10 years 7 monthsSridhar Koganti, Subramaniam Apparsundaram and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cellix Bio Pharma?
Unlock and access historical data on people associated with Cellix Bio Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cellix Bio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellix Bio Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
